Stability Or Chaos? UK Election Result Increases The Uncertainty For Pharma
Executive Summary
UK industry bodies have expressed concern over the result of the UK general election, as the prime minister decides to form a minority government and EU officials say Brexit talks could be delayed.
You may also be interested in...
July Deadline For EMA Relocation Bids; Member States Begin Scrutiny Of Proposed Hosting Criteria
The criteria that candidates seeking to host the European Medicines Agency post-Brexit will have to meet are out for discussion among member state representatives and should be finalized towards the end of June. Formal bids will have to be in by July end and a decision on the EMA’s new home should be made in October.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.